Shares of ARMO Biosciences (NASDAQ: ARMO) soared as much as 67.6% after the company announced that it was acquired by Eli Lilly (NYSE: LLY) for $1.6 billion. The formerly small-cap biopharma wields a ...

ARMO, the Tel Aviv-based company behind Kubescape, the popular open source Kubernetes security platform, today announced that it has raised a $30 million Series A funding round led by Tiger Global.

ARMO CADR minimizes the cloud attack surface, detects and responds to unknown and known cyberattacks while ensuring business continuity, combining the power of CDR and ADR solutions TEL AVIV, IL / ...

TEL AVIV, Israel, Feb. 7, 2023 /PRNewswire/ -- ARMO, creator of open-source Kubernetes security platform Kubescape, announced today that it has integrated ChatGPT's generative AI into ARMO Platform.

INDIANAPOLIS and REDWOOD CITY, Calif., May 10, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and ARMO BioSciences, Inc. (NASDAQ: ARMO) today announced a definitive agreement for Lilly to ...

Eli Lilly plans to acquire Armo BioSciences for approximately $1.6 billion, the companies said today, in a deal that builds the buyer’s immuno-oncology pipeline with a Phase III pancreatic cancer ...

ARMO, developers of a platform that inherently secures cloud-native workloads with in-memory protection coupled with built-in visibility and control, is emerging from stealth after securing $4.5 ...

Eli Lilly has agreed to buy cancer biotech ARMO BioSciences for around $1.6 billion, adding potential cancer immunotherapies to its pipeline. The Indianapolis-based drug firm will pay $50 per share ...

ARMO Ltd., the cloud runtime security company behind the open-source Kubernetes security platform Kubescape, today announced the launch of Behavioral Cloud Application Detection and Response, a new ...